ATS 2019 Virtual Final Program

P508 Pill Aspiration: Metformin Induced Bronchial Stenosis Masquerading as Asthma/ J. Mickelson, E.E. O’Shea Paudel, P.J. Oliveira, Worcester, MA, p.A4685 P509 Inflammatory Myofibroblastic Tumor: A 1 Percenter/ R. Mocerino, V. Kaul, E. Shostak, Elmhurst, NY, p.A4686 BEHAVIORAL THEMATIC POSTER SESSION C37 SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS 9:15 a.m. - 4:15 p.m. KBHCCD Area D (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. P511 Evaluation of End-of-Life Care for Non-Cancer Respiratory Patients Through a Survey of Bereaved Family Members/ R. Imai, A. Mizuno, H. Kanemura, R. Tsugitomi, K. Okafuji, A. Kitamura, Y. Tomishima, T. Jinta, N. Nishimura, T. Tamura, Tokyo, Japan, p.A4687 P512 Estimating Inspiratory Flow Rate and Volume of Inhalation in the Ellipta Using Audio-Based Methods/ T. Taylor, Y. Zigel, E. O’Rourke, E. Kelly, F. Keane, R.W. Costello, R.B. Reilly, Dublin, Ireland, p.A4688 P513 VTE Prophylaxis in Hospitalized Medicine Patients: Too Much of a Good Thing?/ S. Zahid, R. Mazurkiewicz, L. Kirschenbaum, New York, NY, p.A4689 P514 Camped - Experience with Rapid Response Checklist at a Community Hospital/ A. Thota, A. Afghan, S. Ali, N. James, Boston, MA, p.A4690 P515 The Pulmonary Manifestations in End Stage Renal Disease Patients Undergoing Hemodialysis at Bhagwan Mahaveer Jain Hospital/ P.K. Nagendra, H.V. Suryanarayana, Bengaluru, India, p.A4691 P516 Measuring the Positive Impact of Joint Palliative and Respiratory Care in Patient’s with End Stage Respiratory Disease/ P. Chohan, F. Hakkak, H. Ward, Wolverhampton, United Kingdom, p.A4692 P517 The Effects of Support Group Therapy on Patients with Pulmonary Hypertension: A Quality of Life Questionnaire Survey/ G. Stevens, P.C. Giri, J. Merill-Henry, Loma Linda, CA, p.A4693 P518 Multiple RRTs: How Can We Stop Them?/ A. Hilewitz, A. Tsegaye, B. Lee, K.G. Lazo, New Hyde Park, NY, p.A4694 P519 Uptake of Influenza Vaccination as a Preventive Health Care Strategy/ J. Ibrahim, J. Ali, A. Ali, A. Makan, E. Crawford, N. Ahmad, K. Srinivasan, H. Moudgil, Telford, United Kingdom, p.A4695 P520 Effect of Increasing Gas Flow and Resulting Increase in Peak Expiratory Pressure (PEP) from a New Positive Airway Pressure (PAP) Device/ D.P. Coppolo, J. Suggett, V. Kushnarev, Syracuse, NY, p.A4696 P521 Chronic Cough: Differences in Characteristics Between Obese and Non Obese Subjects/ M.M. Descazeaux, D. Brouquières, A. Didier, M. Lescouzeres, R. Escamilla, L. Guilleminault, Toulouse, France, p.A4697 P522 Effect of Continuous Positive Airway Pressure (CPAP) Vs. Sham CPAP in Chronic Unexplained Cough: A Randomized Study (Interim Analysis)/ K. Sundar, A. Willis, S. Smith, H. Fletcher, X. Wang, N. Hu, S.S. Birring, Salt Lake City, UT, p.A4698 P523 Prolongation of Recent-Onset Cough: A Prospective Follow-Up Study Among Finnish Adult Employee Population/ A.M. Lätti, H. Koskela, J. Pekkanen, Kuopio, Finland, p.A4699 P524 Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough/ D. Muccino, A.H. Morice, S.S. Birring, L. McGarvey, P. Dicpinigaitis, I.D. Pavord, A.M. Tershakovec, M.M. Kitt, Y. Zheng, C. Assaid, J. Smith, Rahway, NJ, p.A4700 P525 The Diagnostic Utility of Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease (GERD) in the Diagnosis of GERD-Related Cough/ R. Kurokawa, Y. Kanemitsu, K. Fukumitsu, N. Takeda, J. Maries, H. Nishiyama, K. Ito, S. Fukuda, H. Ohkubo, K. Maeno, Y. Ito, T. Oguri, M. Takemura, A. Niimi, Nagoya, Japan, p.A4701 P526 Different Phenotypes and Severity According to Different Causes of Chronic Cough/ H.-K. Koo, H.K. Kang, H.K. Park, S.H. Park, S.-S. Lee, D.-K. Kim, Goyang-si, Korea, Republic of, p.A4702 P527 Clinical Characteristics and Outcomes in Adult Cystic Fibrosis Patients with Severe Lung Disease in Southern Brazil/ P.R. De Tarso Dalcin, G. Figueiredo da Silva, N. Simmonds, Porto Alegre, Brazil, p.A4703 P528 Use of Point of Care Ultrasound on the Inpatient Pulmonary Consult Service/ N. AlQsous, A. Quintos, P.K. Valestra, M. Rives-Sanchez, W.H. Ahangar, S. Sharma, Philadelphia, PA, p.A4704 P529 Prevalence and Therapeutic Management of Chronic Breathlessness in COPD in a Tertiary Center/ M. Zysman, C. Hortense, C. Morélot-Panzini, P. Julie, G. Emmaniel, G. Anne, P.-R. Burgel, D. Gaetan, S. Pascal, O. Le Rouzic, T. Perez, C. Ari, J.F. Chabot, N. Roche, Creteil, France, p.A4705 P530 Impact of Energy Demand in the Assessment of Dyspnea in Patients with Comorbid and Neuromuscular and Orthopedic Disorders/ C.G. Risk, C. Canavan, Marlborough, MA, p.A4706 P531 Feasibility of a Multi-Component Intervention to Reduce Dyspnea in Patients with Chronic Lung Disease and Severe Obesity: A Pilot Study/ K.L. Dupuy-McCauley, R. Benzo, Rochester, MN, p.A4707 P532 Dyspnea Rating During the Initial Assessment for Pulmonary Function Testing/ P. Chandrika, R.L. ZuWallack, Greenville, NC, p.A4708 ATS 2019 • Dallas, TX 248 TUESDAY • MAY 21